sur BASTIDE (EPA:BLC)
Bastide's Financial Results for 2024-2025 Unveiled
Bastide Group has announced revenue of €491.2 million for the year 2024-2025, reflecting an 8% increase compared to the previous year after restating discontinued operations in accordance with IFRS 5. This figure exceeds the initial target of €560 million, including divested operations.
Key segments, including Respiratory and Nutrition-Perfusion-Stomatherapy-Diabetes, contributed significantly to this performance. The Respiratory segment recorded notable growth of 12.6% and the Nutrition-Perfusion segment posted an increase of 8.1%, mainly due to expansion in the Diabetes sector.
Bastide forecasts an operating margin of 9.1% for 2024-2025. Recent disposals, expected to reduce debt, underscore Bastide's ambition to achieve revenues exceeding €500 million by 2025-2026.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BASTIDE